GlaxoSmithKline

One of our longest standing clients, Equinox Partners have seen this pharmaceutical giant transfrom from Glaxo, to Glaxo Wellcome, to ultimately become GlaxoSmithKline.

One of our longest standing clients, Equinox Partners have seen this pharmaceutical giant transfrom from Glaxo, to Glaxo Wellcome, to ultimately become GlaxoSmithKline.

Our design work included assisting the Device Development Unit in their work on the Diskus Asthma Inhaler, one of the most successful devices the company has produced – netting GSK £7.6bn a year. The first patient leaflet for the device that included coloured illustrations was developed by Equinox Partners – who were then invited to produce the graphics and display cabinets for the Queen's Award for Technology exhibition for this outstanding invention.

The most recent work for GSK was a memorial to Sir David Jack and the the renaming and branding of the Ware development site in Hertfordshire. Sir David was Glaxo's Research and Development Director from 1961 to 1987 and is credited as being the major force to turning the company from a manufacturer of formula baby milk and cough lozenges to the multi-billion dollar pharmaceutical organisation it is today.

Read more...